These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 9787282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Advances in the treatment of Alzheimer's disease.
    Sloane PD.
    Am Fam Physician; 1998 Nov 01; 58(7):1577-86, 1589-90. PubMed ID: 9824956
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar 01; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER.
    J Clin Psychiatry; 1998 Mar 01; 59 Suppl 9():22-7. PubMed ID: 9720483
    [Abstract] [Full Text] [Related]

  • 7. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H, Cummings J.
    Manag Care Interface; 2000 Jan 01; 13(1):51-6. PubMed ID: 10747691
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec 01; 10(56):180-1. PubMed ID: 11824442
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM, Farlow MR.
    Clin Geriatr Med; 2004 Feb 01; 20(1):141-52. PubMed ID: 15062492
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD.
    Am Fam Physician; 1996 Aug 01; 54(2):645-52. PubMed ID: 8701842
    [Abstract] [Full Text] [Related]

  • 18. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun 01; 15(83):103-6. PubMed ID: 16764099
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of Alzheimer's disease].
    López OL, Becker JT.
    Rev Neurol; 2006 Jun 01; 35(9):850-9. PubMed ID: 12436384
    [Abstract] [Full Text] [Related]

  • 20. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN.
    J Clin Psychiatry; 2006 Jun 01; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.